« Back
Home /
Spartalizumab (anti-PD-1)

Spartalizumab (anti-PD-1)

Item no.	A2017-5
Manufacturer	Selleckchem
CASRN	1935694-88-4
Amount	1 mg x 5
Quantity options	1 mg 1 mg x 25 1 mg x 5
Category	Oncology By Cell Type Carcinoma Hematology Lymphoma Myelofibrosis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	PDR001
Available
Manufacturer - Targets	CD279
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Spartalizumab (anti-PD-1) is a humanized anti-PD-1 IgG4 antibody that blocks the binding of PD-L1 and PD-L2 to PD-1. It binds to PD-1 with high affinity and inhibits the biological activity of PD-1, MW: 145.8 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

A2017-5-datasheet.pdf

A2017-5-safety-datasheet.pdf